文献速递生殖医学

评分越高,临床结局越好:自动胚胎评分作为IVF实验室胚胎选择支持工具的回顾性评估

The higher the score, the better the clinical outcome: retrospective evaluation of automatic embryo grading as a support tool for embryo selection in IVF laboratories.
PubMed 文献 · Hum Reprod · 2022-01-01

该回顾性队列研究纳入2018至2020年间1678名接受IVF治疗的患者,其12468枚胚胎在时差培养系统中培养,评估自动胚胎评分作为胚胎选择决策支持工具的临床价值。研究发现,在未进行PGT-A的治疗中,自动评分越高,植入和活产的可能性越大;而在涉及PGT-A的治疗中,评分与植入或活产无显著关联。

要点

  • 自动胚胎评分与未行PGT-A治疗的植入和活产几率直接相关。
  • 在涉及PGT-A的治疗中,胚胎评分与植入或活产无显著关联。
  • 作者认为,该评分可能成为胚胎学家选择囊胚的决策支持工具。

核心结论

  • 根据自动评分系统进行的囊胚评分与植入和活产的可能性直接相关,至少在未进行PGT-A的治疗中如此。

研究设计与样本

  • 回顾性队列研究,纳入2018年至2020年间接受IVF治疗的1678名患者,其12468枚胚胎在时差培养系统中培养。

主要发现

  • 自动胚胎评分在不同形态学类别、整倍体与非整倍体胚胎、妊娠阳性与阴性、植入与非植入以及活产阳性与阴性之间差异显著(P < 0.001)。
  • 在卵母细胞捐赠项目中,胚胎评分与植入几率相关(OR=1.29;95% CI [1.19-1.39];P < 0.001),与活产几率相关(OR=1.26;95% CI [1.16-1.36];P < 0.001)。
  • 在自体卵母细胞的常规治疗中,胚胎评分与植入几率相关(OR=1.38;95% CI [1.24-1.54];P < 0.001),与活产几率相关(OR=1.47;95% CI [1.30-1.65];P < 0.001)。
  • 在涉及PGT-A的治疗中,胚胎评分与植入或活产无显著关联。

临床怎么用

  • 作者认为,自动胚胎评分对不同形态学等级和潜能的胚胎进行排序的临床效率证据,可能使其成为胚胎学家选择囊胚进行胚胎移植时的决策支持工具。

局限性

  • 本研究受其回顾性性质的限制。
  • 需要进一步的前瞻性随机试验来确认这些发现的临床影响。
  • 在考虑该模型的普遍应用时,应考虑到其单中心设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is the automatic embryo grading function of specific time-lapse systems clinically useful as a decision support tool for IVF laboratories? SUMMARY ANSWER: Blastocyst grading according to the automatic scoring system is directly associated with the likelihood of implantation and live birth, at least in treatments without preimplantation genetic testing for aneuploidy (PGT-A). WHAT IS KNOWN ALREADY: Several embryo selection algorithms have been described since the introduction of time-lapse technology in IVF laboratories, but no one algorithm has yet been sufficiently consolidated for universal use. Multicentric models based on automated grading systems offer promise for standardization of embryo selection. STUDY DESIGN, SIZE, DURATION: A retrospective cohort study was performed including 1678 patients who underwent IVF treatments between 2018 and 2020 and whose embryos (n = 12 468) were cultured in time-lapse systems. PARTICIPANTS/MATERIALS, SETTING, METHODS: After obtaining the required parameters (division time to 2, 3, 4 and 5 cells; time of blastocyst formation; inner cell mass quality; and trophectoderm quality), the automatic embryo score was calculated using the software included in the appropriate workstation. First, embryo score was compared with conventional morphological quality and the subsequent clinical outcomes of 1952 single blastocyst transfers. Second, we quantified the contribution of the automatic embryo score and conventional morphological grade to implantation and live birth outcome with multivariate logistic regression analysis in different patient populations. MAIN RESULTS AND THE ROLE OF CHANCE: A higher embryo score was associated with a better clinical outcome of IVF treatment. The mean of the automatic embryo score varied significantly (P < 0.001) among embryos with different morphological categories, between euploid and aneuploid embryos, between embryos resulting in positive versus negative pregnancy, between implanted and non-implanted embryos, and between embryos resulting in positive and negative live birth. Embryo score was related to the odds of implantation and live birth in the oocyte donation program (odds ratio (OR)=1.29; 95% CI [1.19-1.39]; P < 0.001 for implantation and OR = 1.26; 95% CI [1.16-1.36]; P < 0.001 for live birth) and in conventional treatments with autologous oocytes (OR = 1.38; 95% CI [1.24-1.54]; P < 0.001 for implantation and OR = 1.47; 95% CI [1.30-1.65]; P < 0.001 for live birth). There was no significant association of embryo score with implantation or live birth in treatments involving PGT-A. LIMITATIONS, REASONS FOR CAUTION: This study is limited by its retrospective nature. Further prospective randomized trials are required to confirm the clinical impact of these findings. The single-center design should be taken into account when considering the universal application of the model. WIDER IMPLICATIONS OF THE FINDINGS: Evidence of the clinical efficiency of automated embryo scoring for ranking embryos with different morphological grade and potential in order to achieve higher implantation and live birth rates may make it a decision support tool for embryologists when selecting blastocysts for embryo transfer. STUDY FUNDING/COMPETING INTEREST(S): This research has been funded by a grant from the Ministry of Science, Innovation and Universities FIS (PI21/00283) awarded to M.M. There are no competing interests to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Bori L, Meseguer F, Valera MA, et al. The higher the score, the better the clinical outcome: retrospective evaluation of automatic embryo grading as a support tool for embryo selection in IVF laboratories. Hum Reprod. 2022. PMID: 35435210. doi:10.1093/humrep/deac066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。